Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/113189
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Razquin, Cristina | en_US |
dc.contributor.author | Ruiz-Canela, Miguel | en_US |
dc.contributor.author | Toledo, Estefania | en_US |
dc.contributor.author | Hernández-Alonso, Pablo | en_US |
dc.contributor.author | Clish, Clary B. | en_US |
dc.contributor.author | Guasch-Ferré, Marta | en_US |
dc.contributor.author | Li, Jun | en_US |
dc.contributor.author | Wittenbecher, Clemens | en_US |
dc.contributor.author | Dennis, Courtney | en_US |
dc.contributor.author | Alonso-Gómez, Angel | en_US |
dc.contributor.author | Fitó, Montse | en_US |
dc.contributor.author | Liang, Liming | en_US |
dc.contributor.author | Corella, Dolores | en_US |
dc.contributor.author | Gómez-Gracia, Enrique | en_US |
dc.contributor.author | Estruch, Ramon | en_US |
dc.contributor.author | Fiol, Miquel | en_US |
dc.contributor.author | Lapetra, Jose | en_US |
dc.contributor.author | Serra Majem, Luis | en_US |
dc.contributor.author | Ros, Emilio | en_US |
dc.contributor.author | Aros, Fernando | en_US |
dc.contributor.author | Salas-Salvadó, Jordi | en_US |
dc.contributor.author | Hu, Frank B. | en_US |
dc.contributor.author | Martínez-González, Miguel A. | en_US |
dc.date.accessioned | 2022-01-10T14:51:26Z | - |
dc.date.available | 2022-01-10T14:51:26Z | - |
dc.date.issued | 2021 | en_US |
dc.identifier.other | Scopus | - |
dc.identifier.uri | http://hdl.handle.net/10553/113189 | - |
dc.description.abstract | BACKGROUND: The tryptophan-kynurenine pathway is linked to inflammation. We hypothesize that metabolites implicated in this pathway may be associated with the risk of heart failure (HF) or atrial fibrillation (AF) in a population at high risk of cardiovascular disease. OBJECTIVES: We aimed to prospectively analyze the associations of kynurenine-related metabolites with the risk of HF and AF and to analyze a potential effect modification by the randomized interventions of the PREDIMED (Prevención con Dieta Mediterránea) trial with Mediterranean diet (MedDiet). METHODS: Two case-control studies nested within the PREDIMED trial were designed. We selected 324 incident HF cases and 502 incident AF cases individually matched with ≤3 controls. Conditional logistic regression models were fitted. Interactions with the intervention were tested for each of the baseline plasma metabolites measured by LC-tandem MS. RESULTS: Higher baseline kynurenine:tryptophan ratio (OR for 1 SD: 1.20; 95% CI: 1.01, 1.43) and higher levels of kynurenic acid (OR: 1.19; 95% CI: 1.01, 1.40) were associated with HF. Quinolinic acid was associated with AF (OR: 1.15; 95% CI: 1.01, 1.32) and HF (OR: 1.25; 95% CI: 1.04, 1.49). The MedDiet intervention modified the positive associations of kynurenine (Pinteraction = 0.006), kynurenic acid (Pinteraction = 0.008), and quinolinic acid (Pinteraction = 0.033) with HF and the association between kynurenic acid and AF (Pinteraction = 0.02). CONCLUSIONS: We found that tryptophan-kynurenine pathway metabolites were prospectively associated with higher HF risk and to a lesser extent with AF risk. Moreover, an effect modification by MedDiet was observed for the association between plasma baseline kynurenine-related metabolites and the risk of HF, showing that the positive association of increased levels of these metabolites and HF was restricted to the control group. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | The American journal of clinical nutrition | en_US |
dc.source | The American journal of clinical nutrition[EISSN 1938-3207],v. 114 (5), p. 1646-1654, (Noviembre 2021) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 3206 Ciencias de la nutrición | en_US |
dc.subject.other | Atrial Fibrillation | en_US |
dc.subject.other | Case–Control | en_US |
dc.subject.other | Heart Failure | en_US |
dc.subject.other | Kynurenine | en_US |
dc.subject.other | Mediterranean Diet | en_US |
dc.subject.other | Metabolomics | en_US |
dc.subject.other | Predimed | en_US |
dc.subject.other | Tryptophan | en_US |
dc.title | Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1093/ajcn/nqab238 | en_US |
dc.identifier.scopus | 85121950651 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | 0000-0002-7684-2787 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | 0000-0002-9977-8976 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | 0000-0003-3519-8638 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | 0000-0003-1260-4445 | - |
dc.contributor.orcid | 0000-0002-5370-1391 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.authorscopusid | 13612519200 | - |
dc.contributor.authorscopusid | 6603417884 | - |
dc.contributor.authorscopusid | 7003562288 | - |
dc.contributor.authorscopusid | 56239477300 | - |
dc.contributor.authorscopusid | 35460787900 | - |
dc.contributor.authorscopusid | 55110459200 | - |
dc.contributor.authorscopusid | 55872143100 | - |
dc.contributor.authorscopusid | 56669773200 | - |
dc.contributor.authorscopusid | 57130114700 | - |
dc.contributor.authorscopusid | 7004308784 | - |
dc.contributor.authorscopusid | 6602891390 | - |
dc.contributor.authorscopusid | 57216597824 | - |
dc.contributor.authorscopusid | 7003570538 | - |
dc.contributor.authorscopusid | 57202571697 | - |
dc.contributor.authorscopusid | 7005989830 | - |
dc.contributor.authorscopusid | 7005315313 | - |
dc.contributor.authorscopusid | 6507771144 | - |
dc.contributor.authorscopusid | 35596972100 | - |
dc.contributor.authorscopusid | 35474202600 | - |
dc.contributor.authorscopusid | 7004158382 | - |
dc.contributor.authorscopusid | 7003357665 | - |
dc.contributor.authorscopusid | 57208121316 | - |
dc.contributor.authorscopusid | 7004290629 | - |
dc.identifier.eissn | 1938-3207 | - |
dc.description.lastpage | 1654 | en_US |
dc.identifier.issue | 5 | - |
dc.description.firstpage | 1646 | en_US |
dc.relation.volume | 114 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 9 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Noviembre 2021 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 1,833 | |
dc.description.jcr | 8,472 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
dc.description.miaricds | 11,0 | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Nutrición | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-9658-9061 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Serra Majem, Luis | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.